medigraphic.com

2023, Number 4

<< Back Next >>

Rev Mex Anest 2023; 46 (4)

Non-invasive oxygenation methods in patients with COVID-19

López-Reymundo P, Chávez-Requena I, Cruz-Bolaños H, Espinosa-Aznar E, Esquivel-Pineda A, Mazo-Montero B

Language: Spanish
References: 29
Page: 268-271
PDF size: 206.21 Kb.


ABSTRACT

Since the start of the COVID-19 pandemic, the most frequent complications of this infection include pneumonia and Acute Respiratory Distress Syndrome. Hypoxemia and increased work of breathing are determining factors in adopting various non-invasive oxygenation therapeutic strategies in patients with COVID-19. It is important to know and describe the different modalities of non-invasive oxygen therapy, in order to preserve oxygenation and adequate respiratory work, the strategies described in the literature include: conventional nasal cannulas, high-flow nasal cannulas and non-invasive mechanical ventilation coupled with other support measures such as prone position, administration of schemes with steroids, immunomodulators and inhaled nitric oxide. Non-invasive oxygenation strategies by different methods are essential tools for the treatment of patients with moderate-severe COVID-19 pneumonia. It is necessary to evaluate the device to be used, since this disease has heterogeneous characteristics according to severity and time of evolution.


REFERENCES

  1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med. 2020;26:450-452.

  2. Pfeifer M, Ewig S, Voshaar T, Randerath WJ, Bauer T, Geiseler J, et al. Position paper for the state-of-the-art application of respiratory support in patients with COVID-19. Respiration. 2020;99:521-541.

  3. Guideline C. Diagnosis and treatment protocol for novel coronavirus pneumonia (Trial version 7). Chin Med J (Engl). 2020;133:1087-1095.

  4. Hurtado DE, Villarroel N, Andrade C, Retamal J, Bugedo G, Bruhn A. Spatial patterns and frequency distributions of regional deformation in the healthy human lung. Biomech Model Mechanobiol. 2017;16:1413-1423.

  5. Xiaoneng Mo, Wenhua Jian, Zhuquan Su, Mu Chen, Hui Peng, Ping Peng, et al. Abnormal pulmonary function in COVID-19. Eur Respir Soc. 2020;55:2-5. Available from: https://erj.ersjournals.com/content/55/6/2001217

  6. Lang M, Som A, Mendoza DP, Flores EJ, Reid N, Carey D, et al. Correspondence Hypoxaemia related to COVID-19: vascular and. Lancet Infect Dis. 2020;3099:19-20. Available in: http://dx.doi.org/10.1016/S1473-3099(20)30367-4

  7. Hou YJ, Okuda K, Edwards CE, Martinez DR, Asakura T, Dinnon KH, et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell. 2020;182(2):429-446.e14.

  8. George PM, Wells AU, Jenkins RG. Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy. Lancet Respir Med. 2020;8:807-815.

  9. Rai DK, Sharma P, Kumar R. Post covid 19 pulmonary fibrosis. Is it reversible? Indian J Tuberc. 2021;68:330-333.

  10. Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. Conceptions of the pathophysiology of happy hypoxemia in COVID-19. Respir Res. 2021;22:1-9.

  11. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46:1099-1102.

  12. Barrot L, Asfar P, Mauny F, Winiszewski H, Montini F, Badie J, et al. Liberal or conservative oxygen therapy for acute respiratory distress syndrome. N Engl J Med. 2020;382:999-1008.

  13. Ferreyro BL, Angriman F, Munshi L, Del Sorbo L, Ferguson ND, Rochwerg B, et al. Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis. JAMA-J Am Med Assoc. 2020;324:57-67.

  14. Ospina-Tascón GA, Teboul JL, Hernandez G, Alvarez I, Sánchez-Ortiz AI, Calderón-Tapia LE, et al. Diastolic shock index and clinical outcomes in patients with septic shock. Ann Intensive Care. 2020;10:41.

  15. Gattinoni L, Marini JJ, Collino F, Maiolo G, Rapetti F, Tonetti T, et al. The future of mechanical ventilation: Lessons from the present and the past. Crit Care. 2017;21:1-11.

  16. Vega ML, Dongilli R, Olaizola G, Colaianni N, Sayat MC, Pisani L, et al. COVID-19 pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU. Authors' reply. Pulmonology. 2021;27:475-476.

  17. Delorme M, Leroux K, Boussaid G, Lebret M, Prigent H, Leotard A, et al. Protective recommendations for non-invasive ventilation during COVID-19 pandemic: a bench evaluation of the effects of instrumental dead space on alveolar ventilation. Arch Bronconeumol. 2021;57:28-33.

  18. Menzella F, Barbieri C, Fontana M, Scelfo C, Castagnetti C, Ghidoni G, et al. Effectiveness of noninvasive ventilation in COVID-19 related-acute respiratory distress syndrome. Clin Respir J. 2021;15:779-787.

  19. Sorbello M, El-Boghdadly K, Petrini F. Airway management in COVID-19: in the den of the beast. Anesth Analg. 2020;131:e38-e40.

  20. Radovanovic D, Pini S, Saad M, Perotto L, Giuliani F, Santus P. Predictors of weaning from helmet CPAP in patients with COVID-19 pneumonia. Crit Care. 2021;25:1-4.

  21. Duan J, Han X, Bai L, Zhou L, Huang S. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med. 2017;43:192-199.

  22. Papoutsi E, Giannakoulis VG, Xourgia E, Routsi C, Kotanidou A, Siempos II. Effect of timing of intubation on clinical outcomes of critically ill patients with COVID-19: a systematic review and meta-analysis of non-randomized cohort studies. Crit Care. 2021;25(1):121. doi: 10.1186/s13054-021-03540-6.

  23. Shelhamer MC, Wesson PD, Solari IL, Jensen DL, Steele WA, Dimitrov VG, et al. Prone positioning in moderate to severe acute respiratory distress syndrome due to COVID-19: a cohort study and analysis of physiology. J Intensive Care Med. 2021;36:241-252.

  24. Kallet RH. A comprehensive review of prone position in ARDS. Respir Care. 2015;60:1660-1687.

  25. Guérin C, Reignier J, Richard J-C, Beuret P, Gacouin A, Boulain T, et al. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013;368:2159-2168.

  26. Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 does not lead to a "typical" acute respiratory distress syndrome. Am J Respir Crit Care Med. 2020;201:1299-1300.

  27. Parikh R, Wilson C, Weinberg J, Gavin D, Murphy J, Reardon CC. Inhaled nitric oxide treatment in spontaneously breathing COVID-19 patients. Ther Adv Respir Dis. 2020;14:1753466620933510. doi: 10.1177/1753466620933510.

  28. Safaee Fakhr B, Di Fenza R, Gianni S, Wiegand SB, Miyazaki Y, Araujo Morais CC, et al. Inhaled high dose nitric oxide is a safe and effective respiratory treatment in spontaneous breathing hospitalized patients with COVID-19 pneumonia. Nitric Oxide-Biol Chem. 2021;116:7-13.

  29. Wiegand SB, Safaee Fakhr B, Carroll RW, Zapol WM, Kacmarek RM, Berra L. Rescue treatment with high-dose gaseous nitric oxide in spontaneously breathing patients with severe coronavirus disease 2019. Crit Care Explor. 2020;2:e0277.




2020     |     www.medigraphic.com